Yiheng Capital
Latest statistics and disclosures from Yiheng Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SMCI, JD, BILI, NOAH, HTHT, and represent 82.35% of Yiheng Capital Management's stock portfolio.
- Added to shares of these 5 stocks: SMCI (+$567M), YY, GBIO, DBVT, Jianzhi Ed Technology Group Sponsored.
- Started 4 new stock positions in Jianzhi Ed Technology Group Sponsored, GBIO, YY, SMCI.
- Reduced shares in these 10 stocks: RBLX (-$169M), JD (-$85M), EDU (-$50M), HTHT (-$31M), BILI (-$29M), TDG (-$25M), CRSP (-$18M), AKRO (-$12M), VRDN, SGH.
- Sold out of its positions in AIJTY, SGH.
- Yiheng Capital Management was a net buyer of stock by $144M.
- Yiheng Capital Management has $1.8B in assets under management (AUM), dropping by 4.01%.
- Central Index Key (CIK): 0001447228
Tip: Access up to 7 years of quarterly data
Positions held by Yiheng Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Yiheng Capital Management
Yiheng Capital Management holds 22 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Super Micro Computer Put Option (SMCI) | 31.4 | $567M | NEW | 562k | 1010.03 |
|
| Jd.com Spon Adr Cl A (JD) | 27.0 | $487M | -14% | 18M | 27.39 |
|
| Bilibili Spons Ads Rep Z Call Option (BILI) | 15.4 | $279M | -9% | 25M | 11.20 |
|
| Noah Hldgs Spon Ads (NOAH) | 4.3 | $77M | 6.7M | 11.43 |
|
|
| H World Group Sponsored Ads (HTHT) | 4.2 | $76M | -29% | 2.0M | 38.70 |
|
| New Oriental Ed & Technology Spon Adr (EDU) | 3.4 | $61M | -44% | 708k | 86.82 |
|
| Roblox Corp Cl A Call Option (RBLX) | 3.3 | $59M | -74% | 1.6M | 38.18 |
|
| TransDigm Group Incorporated (TDG) | 2.1 | $38M | -39% | 31k | 1231.60 |
|
| Akero Therapeutics (AKRO) | 2.0 | $36M | -25% | 1.4M | 25.26 |
|
| Beam Therapeutics (BEAM) | 1.5 | $28M | 846k | 33.04 |
|
|
| Denali Therapeutics (DNLI) | 1.3 | $24M | 1.2M | 20.52 |
|
|
| Tal Education Group Sponsored Ads (TAL) | 1.2 | $22M | 1.9M | 11.35 |
|
|
| Miragen Therapeutics (VRDN) | 0.9 | $17M | -22% | 948k | 17.51 |
|
| Acm Resh Com Cl A (ACMR) | 0.8 | $14M | -6% | 481k | 29.14 |
|
| Inventiva Sa Ads (IVA) | 0.5 | $9.6M | 2.6M | 3.62 |
|
|
| Dbv Technologies S A Sponsored Adr (DBVT) | 0.2 | $4.2M | +6% | 5.6M | 0.75 |
|
| Joyy Ads Repstg Com A Call Option (YY) | 0.2 | $2.9M | NEW | 93k | 30.75 |
|
| Commscope Hldg (COMM) | 0.1 | $957k | 731k | 1.31 |
|
|
| Generation Bio (GBIO) | 0.0 | $780k | NEW | 192k | 4.07 |
|
| Crispr Therapeutics Namen Akt Put Option (CRSP) | 0.0 | $429k | -97% | 6.3k | 68.16 |
|
| Atre Sponsored Ads (RERE) | 0.0 | $288k | 164k | 1.76 |
|
|
| Jianzhi Ed Technology Group Sponsored Adr | 0.0 | $17k | NEW | 26k | 0.64 |
|
Past Filings by Yiheng Capital Management
SEC 13F filings are viewable for Yiheng Capital Management going back to 2015
- Yiheng Capital Management 2024 Q1 filed May 15, 2024
- Yiheng Capital Management 2023 Q4 filed Feb. 14, 2024
- Yiheng Capital Management 2023 Q3 filed Nov. 14, 2023
- Yiheng Capital Management 2023 Q2 filed Aug. 14, 2023
- Yiheng Capital Management 2023 Q1 filed May 15, 2023
- Yiheng Capital Management 2022 Q4 filed Feb. 14, 2023
- Yiheng Capital Management 2022 Q3 filed Nov. 14, 2022
- Yiheng Capital Management 2022 Q2 filed Aug. 15, 2022
- Yiheng Capital Management 2022 Q1 filed May 16, 2022
- Yiheng Capital Management 2021 Q4 filed Feb. 14, 2022
- Yiheng Capital Management 2021 Q3 filed Nov. 15, 2021
- Yiheng Capital Management 2021 Q2 restated filed Sept. 21, 2021
- Yiheng Capital Management 2021 Q2 filed Aug. 16, 2021
- Yiheng Capital Management 2021 Q1 filed May 17, 2021
- Yiheng Capital Management 2020 Q4 filed Feb. 16, 2021
- Yiheng Capital Management 2020 Q3 filed Nov. 16, 2020